Clinical Trials Browser

Active not recruiting × Hematologic Diseases × Ustekinumab × Clear all

NCT04572815 2026-01-02

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Phase 2 Active not recruiting

Hematologic Diseases